United Orthopedic - Asset Resilience Ratio
United Orthopedic (4129) has an Asset Resilience Ratio of 0.13% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how United Orthopedic's Asset Resilience Ratio has changed over time. Check United Orthopedic (4129) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down United Orthopedic's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see United Orthopedic (4129) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$9.01 Million | 0.13% |
| Total Liquid Assets | NT$9.01 Million | 0.13% |
Asset Resilience Insights
- Limited Liquidity: United Orthopedic maintains only 0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
United Orthopedic Industry Peers by Asset Resilience Ratio
Compare United Orthopedic's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for United Orthopedic (2020–2024)
The table below shows the annual Asset Resilience Ratio data for United Orthopedic.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.13% | NT$9.01 Million ≈ $283.71K |
NT$7.04 Billion ≈ $221.78 Million |
-0.01pp |
| 2023-12-31 | 0.14% | NT$8.89 Million ≈ $279.99K |
NT$6.42 Billion ≈ $202.17 Million |
-0.10pp |
| 2022-12-31 | 0.24% | NT$13.40 Million ≈ $422.21K |
NT$5.62 Billion ≈ $176.92 Million |
-0.27pp |
| 2020-12-31 | 0.51% | NT$28.45 Million ≈ $896.43K |
NT$5.59 Billion ≈ $176.03 Million |
-- |
About United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee… Read more